Septal myectomy after previous septal artery ablation in hypertrophic cardiomyopathy

Mayo Clinic Proceedings

Volumn 82, Issue 12, 2007, Pages 1516-1522

  ElBardissi, Andrew W ^a   Dearani, Joseph A ^a   Nishimura, Rick A ^a   Ommen, Steve R ^a   Stulak, John M ^a   Schaff, Hartzell V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOGRAPHY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOLOGIST; CLINICAL ARTICLE; DEFIBRILLATOR; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE OUTFLOW TRACT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MITRAL VALVE REGURGITATION; MULTIPLE ORGAN FAILURE; MUSCLE RESECTION; PACEMAKER; POSTOPERATIVE COMPLICATION; SEPTAL ARTERY ABLATION; SEPTAL MYECTOMY; SURGICAL MORTALITY; SURGICAL TECHNIQUE;

EID: 36749083426     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.12.1516     Document Type: Article

References (28)

1. Braunwald E, Seidman CE, Sigwart U. Contemporary evaluation and management of hypertrophic cardiomyopathy. Circulation. 2002;106(11):1312-1316.
2. Maron BJ, McKenna WJ, Danielson GK, et al, American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J. 2003;24(21):1965-1991.
3. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol. 1995;26(7):1699-1708.
4. Braunwald E, Wigle ED. Idiopathic hypertrophic subaortic stenosis. Chest. 1973;64(2):222-224.
5. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287(10):1308-1320.
6. Wigle ED, Sasson Z, Henderson MA, et al. Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy: a review. Prog Cardiovasc Dis. 1985;28(1):1-83.
7. Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348(4):295-303.
8. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation. 1995;92(7):1680-1692.
9. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336(11):775-785.
10. Nishimura RA, Holmes DR Jr. Clinical practice: hypertrophic obstructive cardiomyopathy [published correction appears in N Engl J Med. 2004; 350(10): 1038]. N Engl J Med. 2004;350(13):1320-1327.
11. Morrow AG. Hypertrophic subaortic stenosis: operative methods utilized to relieve left ventricular outflow obstruction. J Thorac Cardiovasc Surg. 1978;76(4):423-430.
12. McCully RB, Nishimura RA, Tajik AJ, Schaff HV, Danielson GK. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation. 1996;94(3):467-471.
13. Schulte HD, Borisov K, Gams E, Gramsch-Zabel H, Losse B, Schwartzkopff B. Management of symptomatic hypertrophic obstructive cardiomyopathy-long-term results after surgical therapy. Thorac Cardiovasc Surg. 1999;47(4):213-218.
14. Nagueh SF, Ommen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001;38(6):1701-1706.
15. Qin JX, Shiota T, Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol. 2001;38(7):1994-2000.
16. Maron BJ, Nishimura RA, Danielson GK. Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle. Circulation. 1998;98(23):2505-2508.
17. Minakata K, Dearani JA, Nishimura RA, Maron BJ, Danielson GK. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg. 2004;127(2):481-489.
18. Dearani JA, Danielson GK. Obstructive hypertrophic cardiomyopathy: results of septal myectomy. In: Dearani JA, ed. Diagnosis and Management of Hypertrophic Cardiomyopathy. Malden, MA: Blackwell Futura; 2004:220-235.
19. Dearani JA, Danielson GK. Septal myectomy for obstructive hypertrophic cardiomyopathy. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2005:86-91.
20. Chang SM, Lakkis NM, Franklin J, Spencer WH III, Nagueh SF. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation. 2004 Feb 24;109(7):824-827. Epub 2004 Feb 6.
21. Chang SM, Nagueh SF, Spencer WH III, Lakkis NM. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol. 2003;42(2):296-300.
22. Lakkis NM, Nagueh SF, Dunn JK, Killip D, Spencer WH III. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. J Am Coll Cardiol. 2000;36(3):852-855.
23. Kern MJ, Holmes DG, Simpson C, Bitar SR, Rajjoub H. Delayed occurrence of complete heart block without warning after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc Interv. 2002;56(4):503-507.
24. Faber L, Seggewiss H, Welge D, et al. Predicting the risk of atrioventricular conduction lesions after percutaneous septal ablation for obstructive hypertrophic cardiomyopathy [in German]. Z Kardiol. 2003;92(1):39-47.
25. Talreja DR, Nishimura RA, Edwards WD, et al. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol. 2004;44(22):2329-2332.
26. Kuhn H, Gietzen FH, Leuner C, et al. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy. Z Kardiol. 2000;89(suppl 4):IV41-IV54.
27. Minakata K, Dearani JA, Schaff HV, O'Leary PW, Ommen SR, Danielson GK. Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg. 2005;80(3):851-856.
28. Valeti US, Nishimura RA, Holmes DR, et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007 Jan 23;49(3):350-357. Epub 2007 Jan 4.